The expression of Troponin T1 gene is induced by ketamine in adult mouse brain

Brain Research

Volumn 1174, Issue 1, 2007, Pages 7-17

  Lowe, Xiu R ^a,b,c   Lu, Xiaochen ^b   Marchetti, Francesco ^a,b   Wyrobek, Andrew J ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Ketamine; Metabolic syndrome; Mouse brain; Troponin T1

Indexed keywords

KETAMINE; TROPONIN T; TROPONIN T1; UNCLASSIFIED DRUG; WATER;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DNA MICROARRAY; ENERGY METABOLISM; GENE; GENE EXPRESSION; GENE INDUCTION; HIPPOCAMPUS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MOUSE; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; RNA HYBRIDIZATION; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; TNNT1 GENE;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN DISEASES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOMEOSTASIS; KETAMINE; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED STRAINS; RNA, MESSENGER; TROPONIN T;

MUS;

EID: 34548827031     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.039     Document Type: Article

References (42)

1. Basso D., Millino C., Greco E., Romualdi C., Fogar P., Valerio A., Bellin M., Zambon C.F., Navaglia F., Dussini N., Avogaro A., Pedrazzoli S., Lanfranchi G., and Plebani M. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut 53 8 (2004) 1159-1166
2. Blackwood D.H., Pickard B.J., Thomson P.A., Evans K.L., Porteous D.J., and Muir W.J. Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res. 11 1 (2007) 73-83
3. Bonin M., Poths S., Osaka H., Wang Y.L., Wada K., and Riess O. Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways. Brain Res. Mol. Brain Res. 126 1 (2004) 88-97 Jul 5
4. Casey D.E. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am. J. Med. 118 Suppl 2 (2005) 15S-22S
5. Citrome L. Metabolic syndrome and cardiovascular disease. J. Psychopharmacol. 6 Suppl (2005) 84-93
6. De Vitry F., Hillion J., Catelon J., and Gros F. Myogenic cells in the rat embryonic brain stem. C. R. Acad. Sci. III 317 4 (1994) 332-340
7. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 7 5 (2005) 424-430
8. Fernandez-Medarde A., Porteros A., de Las Rivas J., Nunez A., Fuster J.J., and Santos E. Laser microdissection and microarray analysis of the hippocampus of Ras-GRF1 knockout mice reveals gene expression changes affecting signal transduction pathways related to memory and learning. Neuroscience 146 1 (2007) 272-285
9. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 3 (2002) 356-359
10. Gan L., Zheng W., Chabot J.G., Unterman T.G., and Quirion R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J. Neurochem. 93 5 (2005) 1209-1219
11. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 89 6 (2004) 2595-2600
12. Hayase T., Yamamoto Y., and Yamamoto K. Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neurosci. 7 (2006) 25
13. Hayashi H., Dikkes P., and Soriano S.G. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr. Anaesth. 9 (2002) 770-774
14. Hoekman M.F., Jacobs F.M., Smidt M.P., and Burbach J.P. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr. Patterns 6 2 (2006) 134-140
15. Holt R.I., Peveler R.C., and Byrne C.D. Schizophrenia, the metabolic syndrome and diabetes. Diabet. Med. 21 6 (2004) 515-523
16. Huang H., Regan K.M., Lou Z., Chen J., and Tindall D.J. DK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314 5797 (2006) 294-297
17. Imre G., Fokkema D.S., Den Boer J.A., and Ter Horst G.J. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res. Bull. 69 3 (2006) 338-345 (Apr 14)
18. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., Mochida K., Hata T., Matsuda J., Aburatani H., Nishino I., and Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279 39 (2004) 41114-41123
19. Kim J., Noskov V.N., Lu X., Bergmann A., Ren X., Warth T., Richardson P., Kouprina N., and Stubbs L. Discovery of a novel, paternally expressed ubiquitin-specific processing protease gene through comparative analysis of an imprinted region of mouse chromosome 7 and human chromosome 19q13.4. Genome Res. 8 (2000) 1138-1147
20. Kim M.S., Pak Y.K., Jang P.G., Namkoong C., Choi Y.S., Won J.C., Kim K.S., Kim S.W., Kim H.S., Park J.Y., Kim Y.B., and Lee KU. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 9 7 (2006) 901-906
21. Kim Y.I., Lee F.N., Choi W.S., Lee S., and Youn J.H. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes 55 8 (2006) 2311-2317
22. Kischel P., Bastide B., Muller M., Dubail F., Offredi F., Jin J.P., Mounier Y., and Martial J. Expression and functional properties of four slow skeletal Troponin T isoforms in rat muscles. Am. J. Physiol., Cell Physiol. 289 2 (2005) C437-C443
23. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers Jr. M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51 3 (1994) 199-214
24. Lipton S.A. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J. Alzheimer's dis. 6 6 Suppl (2004) S61-S74
25. Luo C., Lu X., Stubbs L., and Kim J. Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. Genomics 87 3 (2006) 348-355
26. Manji H.K., Quiroz J.A., Payne J.L., Singh J., Lopes B.P., Viegas J.S., and Zarate C.A. The underlying neurobiology of bipolar disorder. World Psychiatry 2 3 (2003) 136-146
27. Matsumoto M., Han S., Kitamura T., and Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116 9 (2006) 2464-2472
28. Miall R.C., and Reckess G.Z. The cerebellum and the timing of coordinated eye and hand tracking. Brain Cogn. 48 1 (2002) 212-226
29. Nakashima K., Yakabe Y., Yamazaki M., and Abe H. Effects of fasting and refeeding on expression of Atrogin-1 and Akt/FOXO signaling pathway in skeletal muscle of chicks. Biosci. Biotechnol. Biochem. 70 11 (2006) 2775-2778
30. Nakki R., Nickolenko J., Chang J., Sagar S.M., and Sharp F.R. Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp. Neurol. 137 2 (1996) 234-241
31. Ryan M.C., Collins P., and Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 160 2 (2003) 284-289
32. Razay G., Vreugdenhil A., and Wilcock G. The metabolic syndrome and Alzheimer disease. Arch. Neurol. 64 1 (2007) 93-96
33. Saba R., and Booth S.A. Target labelling for the detection and profiling of microRNAs expressed in CNS tissue using microarrays. BMC Biotechnol. 12 6 (2006) 47
34. Sato Y., Seo N., and Kobahashi E. The dosing-time dependent effects of intravenous hypnotics in mice. Anesth. Analg. 101 6 (2005) 1706-1708
35. Sharp J.W., Petersen D.L., and Langford M.T. DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex. Brain Res. 687 1-2 (1995) 114-124
36. Thakore J.H., Mann J.N., Vlahos I., Martin A., and Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int. J. Obes. Relat. Metab. Disord. 26 1 (2002) 137-141
37. Thomas W.E. Brain macrophages: evaluation of microglia and their functions. Brain Res. Brain Res. Rev. 17 1 (1992) 61-74
38. Tomiya M., Fukushima T., Kawai J., Aoyama C., Mitsuhashi S., Santa T., Imai K., and Toyo'oka T. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-d-aspartate receptor antagonist, ketamine. Biomed. Chromatogr. 20 6-7 (2006) 628-633
39. Xu Q., Ming Z., Dart A.M., and Du X.J. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin. Exp. Pharmacol. Physiol. 34 5-6 (2007) 499-507
40. Yin E., Nelson D.O., Coleman M.A., Peterson L.E., and Wyrobek A.J. Gene expression changes in mouse brain after exposure to low-dose ionizing radiation. Int. J. Radiat. Biol. 79 10 (2003) 759-775
41. Zarate Jr. C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., and Manji HK. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63 8 (2006) 856-864
42. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., Klotsas A., Matika R., Xiao X., Franks R., Heidenreich K.A., Sajan M.P., Farese R.V., Stolz D.B., Tso P., Koo S.H., Montminy M., and Unterman T.G. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281 15 (2006) 10105-10117